Member Info for bobsson

So last week the BLU telegram group whip themselves into a frenzy, buy more and drive up the share price by 1p on Friday. Its back down by 1p this week because there is little or no progress at Satoshipay. I cannot see why any corporate action involving the reversing of Satoshipay into BLU would take place from a postition of weakness? It makes no corporate sense - the action, if it happens will be when all the Satoshipay offerings gain traction and take off not now. Beware of: Confirmation bias is the unconscious psychological tendency to search for, interpret, favour, and recall information that aligns with your existing beliefs. It essentially acts as a mental filter, causing you to overvalue supporting evidence and ignore facts that contradict what you already think.

Thankfully this BLU thread is not plagued by constant serial rampers. If there is nothing to say the thread goes quiet and we wait for news. However I think we should be much further along the road than we currently are, and a healthy dose of scepticism it totally justified at the moment.

RNS 11.6+ billion shares in issue!

We have a buyer with a stake of over 8% in TCF, 173 + million shares held

LTH here since Evgen 8p days. As a speculative punt I can certainly see why Theracryf may be attractive at 0.24p to buy. If TCFs latest offering continues to show promise there is every chance of a two or three bagger within 12 months, so newbies could be in and out quickly with an excellent profit. For anyone buying now I would suggest avoid holding for more than 12 months. Just cut and run whatever.

IMHO DYOR

Share price 8.5p at the start of 2026 and 8.5p near the end of May 2026. Very poor performance so far from the Satoshipay boys, must do better. So much for my 50p share price prediction for the end of 2026.

I was expecting good news October or November (or both) so happy to wait. Interest from big pharma does not surprise me. I did predict the share price would hit $4 this year and $8 in 2027.

Not a single factor I think, more likely a combination of concern over the product and concerted selling by a major shareholder.

Does look as if NS has lost patience with BLU and continues to sell in the market, and with few interested buyers at present it is little wonder the share price continues to slide. This does not look a "mates rates" trick this time.

Https://www.nasdaq.com/press-release/tiziana-life-sciences-doses-first-patient-phase-2-alzheimers-clinical-trial-2025-12

See news articles from last two days: Alzheimers "wonder drugs" do not work. Targetting Amyloids may not work, but will the combination of Foralumab and these treatments do the trick?

Https://www.nasdaq.com/press-release/tiziana-life-sciences-announces-publication-positive-data-demonstrating-intranasal-0

Large trade posted 16.12 hrs 10th April. 235,000 @ 13.91p for £32,690. Buy or sell?

So Mastercard will not be partnering with Satoshipay?

AFAIK TCF are still in dispute with the company who took SFX under licence. Looks as if SFX is going to fail just like the previous hopeful offering from this company. Its latest offering for "addiction" appears to be miles off proof of efficacy. Yet we still see ramping posts, but you never know it might come good but I have my doubts because of this companies track record of failure.

MAST has a new ticker see QDE

I just wish it would wake up.

I think any placing/dilution at this stage would be simply to keep the lights on at SatoshiPay.

Just need Vortex to keep this momentum up throught 2026. Of great significance to me is the proposed launch into the USA, I just hope it can launch this year. Look forward to any views as to what is known about Alfredpay and the potential for the collaboration.

TTT, I am a LTH as well. Not expecting an RNS because nothing for BLU to report on. Final results last year published on 28th March. Satoshipay have a lot of staff, likely well paid, thats a lot of cash needed to pay the wages and the recent apparent pause in momentum will not help cashflow which is likely to be minimal at this early stage. The rest of BLU`s portfolio not worth much at all.

February will need to be a good month for Satoshipay.

Agreed. WTF is going on?